Evidence mapPaperPMID 20847305Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2010

Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.

Andrew N Hoofnagle, Mingyuan Wu, Albina K Gosmanova, Jessica O Becker, Ellen M Wijsman, John D Brunzell, Steven E Kahn, Robert H Knopp, Timothy J Lyons, Jay W Heinecke

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyValidation Study
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01524705 (FLAT-SUGAR), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01524705 phase4completedstarted 2012, after this paper: background citation

FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR

Ran2012Enrolled102Registered outcomes4Posted comparisons3ConditionsType 2 DiabetesArmsexenatide, Insulin glargine, Metformin, Prandial insulin
Open the trial in the graph
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Andrew N HoofnagleDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA. ahoof@u.washington.edu
Mingyuan Wu
Albina K Gosmanova
Jessica O Becker
Ellen M Wijsman
John D Brunzell
Steven E Kahn
Robert H Knopp
Timothy J Lyons
Jay W Heinecke
University of Oklahoma Health Sciences Center · USUniversity of Washington · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · 1986 to 2025
$12.6M
REVERSE CHOLESTEROL TRANSPORT IN DIABETESP01DK002456 · UNIVERSITY OF WASHINGTON · 1986 to 2005
$9.2M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · UNIVERSITY OF WASHINGTON · 1986 to 2025
$7.0M
Serum Amyloid and Inflammation in AtherogenesisP01HL030086 · UNIVERSITY OF WASHINGTON · 1985 to 2005
$6.9M
Washington University Nutrition Obesity Research CenterP30DK056341 · WASHINGTON UNIVERSITY · 1999 to 2025
$5.7M
NHLBI NIH HHS HL030086NHLBI NIH HHS HL086798NHLBI NIH HHS P01 HL030086NHLBI NIH HHS R01 HL086798NIDDK NIH HHS DK002456NIDDK NIH HHS DK017047NIDDK NIH HHS DK035816NIDDK NIH HHS P01 DK002456NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

objectiveTo determine whether obesity and insulin resistance associate with changes in the protein content of high-density lipoprotein (HDL) in 2 different groups of men by using targeted proteomics. METHODS AND

resultsInsulin resistance and obesity are hallmarks of type 2 diabetes mellitus and the metabolic syndrome, which confer an increased risk of cardiovascular disease. Recent studies suggest that the protein cargo of HDL makes important contributions to the lipoprotein's cardioprotective effects. In a discovery study, we used isotope dilution mass spectrometry to quantify the relative concentrations of 5 proteins previously implicated in HDL's cardioprotective effects in 3 groups of healthy subjects: lean insulin-sensitive, lean insulin-resistant, and obese insulin-resistant individuals. We validated our findings in a different group of subjects. The clusterin concentration in HDL strongly and negatively associated with insulin resistance and body mass index in both populations. HDL clusterin levels were lower in subjects with low HDL and high triglycerides, key components of the metabolic syndrome. There was an inverse correlation between clusterin levels in HDL and very-low-density lipoprotein/low-density lipoprotein.

conclusionsClusterin levels in HDL are lower in men with reduced insulin sensitivity, higher body mass index, and an unfavorable lipid profile. Our observations raise the possibility that clusterin depletion contributes to the loss of HDL's cardioprotective properties.

Indexed as

Insulin ResistanceAdultBiomarkersBody Mass IndexCase-Control StudiesChromatography, LiquidClusterinDiabetes Mellitus, Type 2Down-RegulationDyslipidemiasHumansIndicator Dilution TechniquesLipoproteins, HDLMaleMetabolic SyndromeMiddle AgedBiomarkersCLU protein, humanClusterinLipoproteins, HDLTriglycerides

Identifiers

PMID20847305
PMCPMC2988100
OpenAlexW2124663131

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.